for others, it strains intimacy and communication
GLP-1-RA such as liraglutide [4], semaglutide [5], and the dual agonist tirzepatide [6], activating both the GLP1- and the gastric-inhibitory polypeptide receptor (GIP-R), have been shown to significantly reduce body weight, making them a promising therapeutic option for the treatment of obesity
This has led to a dramatic increase in body contouring procedures, with liposuction searches increasing 144% year-over-year among GLP-1 users seeking to refine their results
Progress compounds if habits stay steady
Benzodiazepines + Opioids Mechanism: Additive CNS and respiratory depression overdose risk 8
Section 3 Consumer Trend Overview In recent years, public interest in gut health has grown beyond general digestion concerns to include broader metabolic and lifestyle dimensions